Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
The current Eli Lilly(LLY) stock price is $1,077.10, with a market capitalization of 1.02T. The stock trades at a price-to-earnings (P/E) ratio of 53.00 and offers a dividend yield of 56.0%.
As of 2025-12-24, Eli Lilly(LLY) stock has fluctuated between $1,072.65 and $1,085.73. The current price stands at $1,077.10, placing the stock +0.4% above today's low and -0.8% off the high.
Eli Lilly(LLY) shares are trading with a volume of 932.37K, against a daily average of 3.76M.
In the last year, Eli Lilly(LLY) shares hit a 52-week high of $1,111.99 and a 52-week low of $623.78.
In the last year, Eli Lilly(LLY) shares hit a 52-week high of $1,111.99 and a 52-week low of $623.78.
LLY News
Rumors persist that U.S. pharmaceutical giant Eli Lilly (LLY) will split its stock in the New Year. Claim 70% Off TipRanks This Holiday Season LLY stock has b...
Rumors have circulated that French biotechnology company Abivax (ABVX) has been attracting interest from Eli Lilly (LLY), according to a report in the French-la...
U.S.-based Eli Lilly & Co. (LLY) and Danish drug maker Novo Nordisk (NVO) are vying to capture a large portion of India’s rapidly growing obesity drug market. L...
Analyst ratings
77%
of 31 ratingsMore LLY News
The approval of Novo Nordisk's (NYSE:NVO) oral Wegovy is bringing new interest to health care and pharmaceutical ETFs that provide access to the growing GLP-1 m...
Eli Lilly and Company (NASDAQ:LLY) shares are trading down on Tuesday as investors weigh the competitive landscape in the pharmaceutical sector. Eli Lilly stock...
Shares of Eli Lilly (LLY) are down about 1% in early trading on Dec. 23 on news that archrival Novo Nordisk’s (NVO) new weight-loss pill has received regulatory...
Biotech and Pharma Novo Nordisk Stock Soars After Weight-Loss Pill Approved in U.S. What It Means for Eli Lilly. In this article LLY NOVO.B The U.S. Food and Dr...
This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herei...
As investors look beyond mega-cap tech for the next leg of growth, pharma is quietly moving back into focus — and no two names capture that shift better than El...
Before, they had to be injected, but now Novo Norkish has secured FDA approval for the oral version of its Wegovy weight-loss drug - beating its rival Eli Lilly...
